-
公开(公告)号:US12220485B2
公开(公告)日:2025-02-11
申请号:US18457090
申请日:2023-08-28
Applicant: Arcturus Therapeutics, Inc.
Inventor: Priya Karmali , Padmanabh Chivukula , Joseph E. Payne , Yanjie Bao , Michael Figa , Scott A. Roberts , Andreas Wagner
Abstract: A method of producing a lipid-encapsulated RNA nanoparticle, comprising the steps a) flowing an aqueous solution comprising an RNA through a 1st tube having an inner diameter (ID) of between about 0.1″ and 0.132″; b) flowing an ethanol solution comprising lipids through a 2nd tube having an ID of between about 0.005″ and 0.02″ at one third the flow rate of the aqueous solution through the 1st tube, wherein the lipids comprise a cationic lipid; and c) mixing the ethanol solution with the aqueous solution by flowing the ethanol solution and the aqueous solution into a mixing module consisting of the 2nd tube perpendicularly joined to the 1st tube; wherein the mixing produces an output solution flowing in the 1st tube comprising a turbulent flow of the RNA and the lipids in between about 10% to 75% ethanol v/v, and wherein the lipid-encapsulated RNA nanoparticles have a bilayer structure.
-
公开(公告)号:US20230398076A1
公开(公告)日:2023-12-14
申请号:US18457090
申请日:2023-08-28
Applicant: Arcturus Therapeutics, Inc.
Inventor: Priya Karmali , Padmanabh Chivukula , Joseph E. Payne , Yanjie Bao , Michael Figa , Scott A. Roberts , Andreas Wagner
CPC classification number: A61K9/1277 , A61K9/145 , A61K47/60 , A61K47/69 , B82Y5/00
Abstract: A method of producing a lipid-encapsulated RNA nanoparticle, comprising the steps a) flowing an aqueous solution comprising an RNA through a 1st tube having an inner diameter (ID) of between about 0.1″ and 0.132″; b) flowing an ethanol solution comprising lipids through a 2nd tube having an ID of between about 0.005″ and 0.02″ at one third the flow rate of the aqueous solution through the 1st tube, wherein the lipids comprise a cationic lipid; and c) mixing the ethanol solution with the aqueous solution by flowing the ethanol solution and the aqueous solution into a mixing module consisting of the 2nd tube perpendicularly joined to the 1st tube; wherein the mixing produces an output solution flowing in the 1st tube comprising a turbulent flow of the RNA and the lipids in between about 10% to 75% ethanol v/v, and wherein the lipid-encapsulated RNA nanoparticles have a bilayer structure.
-